Table IV.
Risk factors for efficacy of hip replacement.
| 95% CI of EXP (B) | |||||||
|---|---|---|---|---|---|---|---|
| Factors | B | SD | Wals | Sig. | Exp (B) | Lower limit | Upper limit |
| Age | 2.122 | 0.515 | 16.961 | 0.009 | 8.345 | 3.04 | 22.904 |
| BMI | 1.65 | 0.503 | 10.765 | 0.015 | 5.207 | 1.943 | 13.951 |
| CXC13 | 1.353 | 0.485 | 7.785 | 0.005 | 3.867 | 1.496 | 10.001 |
| IL-6 | 0.848 | 0.471 | 3.245 | 0.008 | 2.335 | 0.928 | 5.873 |
| Diabetes history | 0.201 | 0.478 | 0.177 | 0.032 | 1.223 | 0.479 | 3.121 |
| Hypertension history | 0.804 | 0.498 | 2.605 | 0.034 | 2.233 | 0.842 | 5.926 |
| Hyperlipidemia history | 0.56 | 0.489 | 1.313 | 0.025 | 1.751 | 0.672 | 4.562 |
B, constant term; SD, standard deviation; Wals, chi-square value; sig, P-value; Exp (B), dominance ratio; 95% CI of EXP (B), 95% confidence interval of dominance ratio; BMI, body mass index; CXCL13, serum chemokine CXC ligand 13; IL-6, interleukin-6.